Comments on: From Bench to Bedside http://biobiz.sg/2009/02/from-bench-top-to-bed-side/ Sparking connections Wed, 09 Mar 2011 14:31:20 +0000 hourly 1 http://wordpress.org/?v=3.3.1 By: <fb:name linked="false" useyou="false" uid="681090663">Ding Yi Xin</fb:name> http://biobiz.sg/2009/02/from-bench-top-to-bed-side/comment-page-1/#comment-81 Ding Yi Xin Sat, 28 Feb 2009 15:39:46 +0000 http://biobiz.sg/?p=471#comment-81 12 years and 10 months do sound like a long journey. What are some of the latest practices that pharmaceutical companies adopt to shorten the process? Who are the people involved at various stages and what specific roles do they play? 12 years and 10 months do sound like a long journey. What are some of the latest practices that pharmaceutical companies adopt to shorten the process?

Who are the people involved at various stages and what specific roles do they play?

]]> By: MH http://biobiz.sg/2009/02/from-bench-top-to-bed-side/comment-page-1/#comment-67 MH Thu, 26 Feb 2009 02:41:47 +0000 http://biobiz.sg/?p=471#comment-67 This long and often expensive process to discovering a new drug has very often resulted in very expensive patented drugs. The cost can potentially prevent patients from reaping the benefits of the drug-- the very persons whom the drug is developed for. Is there any way where the interests of the large pharma companies and patients can be reconciled? Government subsidies? Perhaps, but would that encourage the pharma companies to increase the selling price? This long and often expensive process to discovering a new drug has very often resulted in very expensive patented drugs. The cost can potentially prevent patients from reaping the benefits of the drug– the very persons whom the drug is developed for. Is there any way where the interests of the large pharma companies and patients can be reconciled? Government subsidies? Perhaps, but would that encourage the pharma companies to increase the selling price?

]]>